Information

  • Search
  • Inquiry
    icon
  • Why Us?
    icon
  • How It Works
    icon

Medical News

Emergent Notification! (Finding Somebody, Who has ADVANCED SOLID TUMOUR , but could not have treatment yet)
Attached File 2019-03-13 565

 

Clinical Trial on Advanced Solid Tumour Patient


Official Title:

A Phase 1 First-in-Human Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR441000 Administered Intratumorally as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumours


Estimated Clinical Trial Completion Date: December 2021


Condition or disease:

Metastatic Neoplasm


Intervention/treatment:

Drug:SAR441000/Cemiplimab REGN2810


Detailed De[removed]ion:

The expected duration of treatment for patients who benefit from clinical intervention may vary, based on progression date. Median expected duration of study per patient is estimated as 9 months in monotherapy and 12 months in combination therapy. The maximum treatment duration for non-progressive patients is up to 52 weeks.


Eligibility:


Age: 18 years and older, Adult

Sex: All

Nationality: all


Advanced solid malignant tumour disease for which no standard alternative therapy is available.

Advanced melanoma (Stage IIIB-C or Stage IV, anti-PD-1/PD-L1 treated or not) or anti-PD-1/PD-L1 not treated advanced Head and Neck Squamous Cell Cancer or Advanced Cutaneous Squamous Cell Cancer where no other alternative treatment option exists (expansion phase)


Minimum 2 malignant lesions

 

 

 

Contact: https://searchhospital.com or herryforter@gmail.com


리스트